Severe thrombocytopenia in a patient with hepatitis C treated with eltrombopag from off-label drug use to on-label drug use: a case report

INTRODUCTION: Off-label drug use refers to drug use beyond the specifications authorized for marketing. Eltrombopag is a new thrombopoietin receptor agonist which was used successfully in this critical case of thrombocytopenia associated with hepatitis C infection before it became an approved drug f...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Jafar, Hassan A, Al-Khaldi, Jameela, Alduaij, Ahmad, Al-Banwan, Khalifa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4174391/
https://www.ncbi.nlm.nih.gov/pubmed/25209590
http://dx.doi.org/10.1186/1752-1947-8-303

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4174391/
https://www.ncbi.nlm.nih.gov/pubmed/25209590
http://dx.doi.org/10.1186/1752-1947-8-303

Ejemplares similares